Skip to content

Clinical trials

Completed Phase 2 Mental Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 2 Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20051
20062
20073
20082
20091
20102
20116
20123
20132
20145
20151
20161
20173
20185
20194
20204
20216
20229
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)7
Alkahest, Inc.3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
University of California, San Diego3
AbbVie2
Corcept Therapeutics2
Marinus Pharmaceuticals2
National Institute on Drug Abuse (NIDA)2
Novartis Pharmaceuticals2
Radboud University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders78
Schizophrenia20
Dementia14
Brain Diseases12
Mood Disorders12
Nervous System Diseases12
Neurologic Manifestations12
Central Nervous System Diseases11
Psychotic Disorders11
Rare Diseases11

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.